Adverse Event Clinical Research R4 Backport
1.0.1 - STU1 International flag

This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

MedicationAdministration: medication-administration-kadcyla

Page standards status: Informative

Generated Narrative: MedicationAdministration

Resource MedicationAdministration "medication-administration-kadcyla"

status: completed

medication: KADCYLA (RxNorm#1371046)

subject: Patient/patient-example-kaitlyn-b " BOUNCE"

effective: 2020-04-01

Performers

-Actor
*Practitioner/practitioner-oncology-nurse-jane " NURSE"

request: MedicationRequest/medication-request-example-kadcyla

note: 3.6mg administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/practitioner-oncology-nurse-jane @2020-04-01)

Dosages

-RouteDose
*Intravenous route (qualifier value) (SNOMED CT#47625008)3.6 mg (Details: UCUM code mg = 'mg')